APON(SZ:300753) Xin Lang Cai Jing·2025-08-26 07:41Group 1 - The core viewpoint of the news is that Aipeng Medical's stock has experienced a decline of 5.02%, with a current price of 34.47 CNY per share and a total market capitalization of 4.345 billion CNY [1] - Aipeng Medical, established on October 30, 2001, specializes in the development, production, and sales of medical devices in the pain management and nasal care sectors [1] - The company's revenue composition includes 61.52% from pain management products, 30.55% from nasal and upper airway products, 7.55% from other products, and 0.37% from other businesses [1] Group 2 - Among the top circulating shareholders of Aipeng Medical, Huaxia Fund's Huaxia Innovation Future Mixed Fund (LOF) has recently entered the top ten, holding 589,700 shares, which is 0.67% of the circulating shares [2] - The Huaxia Innovation Future Mixed Fund (LOF) was established on October 13, 2020, with a latest scale of 2.265 billion CNY and has achieved a year-to-date return of 33.22% [2] - The fund's performance over the past year shows a return of 57.97%, ranking 1810 out of 7962 in its category, while it has experienced a cumulative loss of 31.38% since inception [2]